Home / Companies / Glycan Therapeutics Corporation
Glycan Therapeutics Corporation H-1B company data
Summary
Glycan Therapeutics Corporation filed 2 H-1B labor condition applications (LCAs) with the U.S. Department of Labor between FY2021.
Of those, 2 were certified (a 100% certification rate among adjudicated filings).
The filings span 1 distinct role titles across 1 worksites.
The most-sponsored role was Senior Accountant (2 filings), with offered wages from $80,000 to $80,001.
Separately, USCIS H-1B Employer Data Hub records show 1 approved and 0 denied H-1B petitions for this employer.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Employer | LCA filings | Role titles | Worksites | Coverage | USCIS approvals | Top role | Sources | Open |
|---|---|---|---|---|---|---|---|---|
| Glycan Therapeutics Corporation GLYCAN THERAPEUTICS CORPORATION | 2 | 1 | 1 | FY2021 to FY2021 Latest decision 2021-02-24 | 1 | Senior Accountant 2 filings | dol_oflc_lca, uscis_h1b_employer_data_hub | Profile |
Activity summary
| LCA filings | 2 |
| Certified LCAs | 2 |
| Denied LCAs | 0 |
| Role titles | 1 |
| Worksites | 1 |
| Latest decision | 2021-02-24 |
| USCIS approvals | 1 |
| USCIS denials | 0 |
Aliases and source names
| Aliases | Source Names | Sources |
|---|---|---|
| GLYCAN THERAPEUTICS CORPORATION | Glycan Therapeutics Corporation, GLYCAN THERAPEUTICS CORPORATION | dol_oflc_lca, uscis_h1b_employer_data_hub |
Top roles
| Title | SOC | LCA filings | Low wage min | High wage max |
|---|---|---|---|---|
| Senior Accountant | 13-2011.01 Accountants | 2 | $80,000 | $80,001 |
Top markets
| City | State | Postal Code | LCA Count | Role Title Count | Wage Low Min | Wage High Max | First Fiscal Year | Latest Fiscal Year |
|---|---|---|---|---|---|---|---|---|
| Raleigh | NC | 27606 | 2 | 1 | 80,000 | 80,001 | 2,021 | 2,021 |
Full company payload
| Company ID | company:glycan therapeutics |
| Name | Glycan Therapeutics Corporation |
| Normalized Name | glycan therapeutics |
| Source Company Ids | company_dol_oflc_lca_glycan_therapeutics_corporation, company_uscis_h1b_datahub_glycan_therapeutics_corporation_tax_2475 |
| Source Names | Glycan Therapeutics Corporation, GLYCAN THERAPEUTICS CORPORATION |
| Aliases | GLYCAN THERAPEUTICS CORPORATION |
| Sources | dol_oflc_lca, uscis_h1b_employer_data_hub |
Names
{
"source_names": [
"Glycan Therapeutics Corporation",
"GLYCAN THERAPEUTICS CORPORATION"
],
"dba_names": [],
"name_variants": [
{
"value": "Glycan Therapeutics Corporation",
"filing_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"source": "dol_oflc_lca"
},
{
"value": "GLYCAN THERAPEUTICS CORPORATION",
"source": "uscis_h1b_employer_data_hub"
}
]
}Identifiers
[
{
"identifier_type": "tax_id_last_four",
"identifier_value": "2475",
"source": "uscis_h1b_employer_data_hub"
}
]LCA Activity
{
"lca_count": 2,
"case_count": 2,
"role_title_count": 1,
"worksite_count": 1,
"total_workers": 2,
"first_fiscal_year": 2021,
"first_received_date": "2021-02-17",
"latest_fiscal_year": 2021,
"latest_decision_date": "2021-02-24",
"certified_count": 2,
"denied_count": 0,
"status_breakdown": [
{
"value": "Certified",
"filing_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"source": "dol_oflc_lca"
}
],
"visa_class_breakdown": [
{
"value": "H-1B",
"filing_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"source": "dol_oflc_lca"
}
],
"full_time_position_breakdown": [
{
"value": "Y",
"filing_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"source": "dol_oflc_lca"
}
]
}Petition Activity
{
"initial_approval": 0,
"initial_denial": 0,
"continuing_approval": 0,
"continuing_denial": 0,
"total_approval": 1,
"total_denial": 0,
"fiscal_years": [
"2021"
],
"year_metrics": [
{
"cities": [
"Raleigh"
],
"states": [
"NC"
],
"fiscal_year": 2021,
"naics_codes": [
"99"
],
"postal_codes": [
"27606"
],
"total_denial": 0,
"initial_denial": 0,
"total_approval": 1,
"initial_approval": 0,
"continuing_denial": 0,
"petition_count_id": "petition_count_uscis_h1b_archive_glycan_therapeutics_corporation_tax_2475_2021",
"source_record_ids": [
"sr_uscis_h1b_datahub_2021_row_022010"
],
"continuing_approval": 1
}
]
}Addresses
{
"office_addresses": [
{
"address_kind": "office",
"raw_address": "RALEIGH NC 27606",
"city": "Raleigh",
"state": "NC",
"postal_code": "27606",
"filing_count": 2,
"case_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"latest_decision_date": "2021-02-24",
"source_ids": [
"dol_oflc_lca"
]
}
],
"worksite_addresses": [
{
"address_kind": "worksite",
"raw_address": "RALEIGH NC 27606",
"city": "Raleigh",
"county": "Wake",
"state": "NC",
"postal_code": "27606",
"filing_count": 2,
"case_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"latest_decision_date": "2021-02-24",
"source_ids": [
"dol_oflc_lca"
]
}
],
"summary": {
"office_address_count": 1,
"worksite_address_count": 1,
"has_street_address_evidence": true,
"caveat": "LCA employer/worksite addresses are capped filing evidence scoped to matched source company names and should not be treated as verified headquarters without external validation."
}
}Geography
{
"states": [
"NC"
],
"cities": [
"Raleigh"
],
"postal_codes": [
"27606"
],
"top_markets": [
{
"city": "Raleigh",
"state": "NC",
"postal_code": "27606",
"lca_count": 2,
"role_title_count": 1,
"wage_low_min": 80000,
"wage_high_max": 80001,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021
}
]
}Industry
{
"naics_codes": [
"541714",
"99"
],
"naics_breakdown": [
{
"value": "541714",
"filing_count": 2,
"first_fiscal_year": 2021,
"latest_fiscal_year": 2021,
"source": "dol_oflc_lca"
}
]
}Wage Summary
{
"annualized_low_min": 80000,
"annualized_high_max": 80001,
"annualized_low_avg": 80000
}Trend
[
{
"fiscal_year": 2021,
"quarter": "Q2",
"lca_count": 1,
"case_count": 1,
"role_title_count": 1,
"worksite_count": 1,
"wage_low_min": 80000,
"wage_high_max": 80001,
"wage_low_avg": 80000
},
{
"fiscal_year": 2021,
"quarter": "Q3",
"lca_count": 1,
"case_count": 1,
"role_title_count": 1,
"worksite_count": 1,
"wage_low_min": 80000,
"wage_high_max": 80001,
"wage_low_avg": 80000
}
]Links
{
"roles": "/v1/roles?company=Glycan%20Therapeutics%20Corporation",
"wages": "/v1/wages?company=Glycan%20Therapeutics%20Corporation",
"trends": "/v1/trends?company=Glycan%20Therapeutics%20Corporation"
}Frequently asked questions
- Does Glycan Therapeutics Corporation sponsor H-1B visas?
- Yes. Glycan Therapeutics Corporation filed 2 H-1B labor condition applications with the U.S. Department of Labor (FY2021), of which 2 were certified. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
- How many H-1B applications has Glycan Therapeutics Corporation filed?
- Glycan Therapeutics Corporation has 2 H-1B LCA filings on record spanning FY2021 across 1 role titles and 1 worksites.
- What roles does Glycan Therapeutics Corporation sponsor for H-1B?
- The most common H-1B role at Glycan Therapeutics Corporation is Senior Accountant (2 filings).
- What wages does Glycan Therapeutics Corporation offer H-1B workers?
- For its most-sponsored role (Senior Accountant), Glycan Therapeutics Corporation reported offered wages ranging from $80,000 to $80,001 in DOL LCA filings.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/companies?q=glycan+therapeutics+corporation&limit=5JSON